Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,925 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
Amagai M, Ikeda S, Hashimoto T, Mizuashi M, Fujisawa A, Ihn H, Matsuzaki Y, Ohtsuka M, Fujiwara H, Furuta J, Tago O, Yamagami J, Tanikawa A, Uhara H, Morita A, Nakanishi G, Tani M, Aoyama Y, Makino E, Muto M, Manabe M, Konno T, Murata S, Izaki S, Watanabe H, Yamaguchi Y, Matsukura S, Seishima M, Habe K, Yoshida Y, Kaneko S, Shindo H, Nakajima K, Kanekura T, Takahashi K, Kitajima Y, Hashimoto K; Bullous Pemphigoid Study Group. Amagai M, et al. Among authors: hashimoto k, hashimoto t. J Dermatol Sci. 2017 Feb;85(2):77-84. doi: 10.1016/j.jdermsci.2016.11.003. Epub 2016 Nov 9. J Dermatol Sci. 2017. PMID: 27876358 Clinical Trial.
A randomized double-blind trial of intravenous immunoglobulin for pemphigus.
Amagai M, Ikeda S, Shimizu H, Iizuka H, Hanada K, Aiba S, Kaneko F, Izaki S, Tamaki K, Ikezawa Z, Takigawa M, Seishima M, Tanaka T, Miyachi Y, Katayama I, Horiguchi Y, Miyagawa S, Furukawa F, Iwatsuki K, Hide M, Tokura Y, Furue M, Hashimoto T, Ihn H, Fujiwara S, Nishikawa T, Ogawa H, Kitajima Y, Hashimoto K; Pemphigus Study Group. Amagai M, et al. Among authors: hashimoto k, hashimoto t. J Am Acad Dermatol. 2009 Apr;60(4):595-603. doi: 10.1016/j.jaad.2008.09.052. J Am Acad Dermatol. 2009. PMID: 19293008 Clinical Trial.
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigus.
Yamagami J, Ujiie H, Aoyama Y, Ishii N, Tateishi C, Ishiko A, Ichijima T, Hagihara S, Hashimoto K, Amagai M. Yamagami J, et al. Among authors: hashimoto k. J Dermatol Sci. 2021 Sep;103(3):135-142. doi: 10.1016/j.jdermsci.2021.07.002. Epub 2021 Jul 6. J Dermatol Sci. 2021. PMID: 34376340 Free article. Clinical Trial.
Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.
Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, Schmidt E, Zillikens D, Shirakata Y, Hashimoto K, Kitajima Y, Amagai M. Saleh MA, et al. Among authors: hashimoto k, hashimoto t. J Dermatol Sci. 2011 Jun;62(3):169-75. doi: 10.1016/j.jdermsci.2011.03.003. Epub 2011 Mar 16. J Dermatol Sci. 2011. PMID: 21482078
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T; SJS/TEN Study Group. Aihara M, et al. Among authors: hashimoto k. J Dermatol. 2015 Aug;42(8):768-77. doi: 10.1111/1346-8138.12925. Epub 2015 May 18. J Dermatol. 2015. PMID: 25982480 Clinical Trial.
TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS).
Uno H, Kabashima K, Tohyama M, Watanabe T, Hashimoto K, Iijima M, Sueki H, Watanabe H. Uno H, et al. Among authors: hashimoto k. J Dermatol Sci. 2014 May;74(2):177-9. doi: 10.1016/j.jdermsci.2014.01.007. Epub 2014 Jan 24. J Dermatol Sci. 2014. PMID: 24517870 No abstract available.
Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K, Morito H, Hasegawa A, Daikoku N, Miyagawa F, Okazaki A, Fukumoto T, Kobayashi N, Kasai T, Watanabe H, Sueki H, Iijima M, Tohyama M, Hashimoto K, Asada H. Ogawa K, et al. Among authors: hashimoto k. J Dermatol Sci. 2013 Jan;69(1):38-43. doi: 10.1016/j.jdermsci.2012.10.002. Epub 2012 Oct 26. J Dermatol Sci. 2013. PMID: 23141052
7,925 results